Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition

H. S. Kim, M. Jung, H. N. Kang, H. Kim, C. W. Park, S. M. Kim, S. J. Shin, S. H. Kim, S. G. Kim, E. K. Kim, M. R. Yun, Z. Zheng, K. Y. Chung, J. Greenbowe, S. M. Ali, T. M. Kim, B. C. Cho

Research output: Contribution to journalArticlepeer-review

53 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition'. Together they form a unique fingerprint.

Medicine & Life Sciences